ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract ...

ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract ...

In the last three months, 11 analysts have published ratings on RxSight RXST, offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

Shares of RXST opened at $28.36 on Wednesday. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of -34.17 and a beta of 1.19. RxSight has a fifty-two week low of $26.29 and a ...

Last week, you might have seen that RxSight, Inc. ( NASDAQ:RXST ) released its annual result to the market. The early... RxSight ( NASDAQ:RXST ) Full Year 2024 Results Key Financial Results ...